Importance of triple tumor markers as biomarkers in patients with pancreatic ductal adenocarcinoma

Importance of triple tumor markers as biomarkers in patients with pancreatic ductal adenocarcinoma

Abstract Aim There is an urgent need to establish biomarkers for the treatment of pancreatic ductal adenocarcinoma (PDAC). The aim of this study was to investigate the usefulness of the combined assessment of carbohydrate antigen 19‐9 (CA19‐9), carcinoembryonic antigen (CEA), and duke pancreatic mon...

Full description

Bibliographic Details
Main Authors: Tadataka Takagi, Minako Nagai, Satoshi Nishiwada, Taichi Terai, Satoshi Yasuda, Yasuko Matsuo, Shunsuke Doi, Yuichiro Kohara, Masayuki Sho
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:Annals of Gastroenterological Surgery
Subjects:
biomarker
neoadjuvant chemoradiation
pancreatic ductal adenocarcinoma
tumor marker
upfront surgery
Online Access:https://doi.org/10.1002/ags3.12629

Internet

https://doi.org/10.1002/ags3.12629

Similar Items